PMC:7546716 / 25292-25639 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T475","span":{"begin":102,"end":106},"obj":"Body_part"},{"id":"T476","span":{"begin":158,"end":163},"obj":"Body_part"},{"id":"T477","span":{"begin":180,"end":182},"obj":"Body_part"},{"id":"T478","span":{"begin":201,"end":206},"obj":"Body_part"},{"id":"T479","span":{"begin":280,"end":286},"obj":"Body_part"}],"attributes":[{"id":"A475","pred":"fma_id","subj":"T475","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A476","pred":"fma_id","subj":"T476","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A477","pred":"fma_id","subj":"T477","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A478","pred":"fma_id","subj":"T478","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A479","pred":"fma_id","subj":"T479","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"Production of soluble ST2 might be reduced by anti-ST2 treatment, and such reduction would modulate T-cell polarisation by decreasing pathogenic Th1 and Th17 cells, and increasing IL-10-producing Treg cells.67 Future research should focus on whether soluble ST2 concentrations in plasma have prognostic value in patients with COVID-19 (figure 2 )."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T147","span":{"begin":326,"end":334},"obj":"Disease"}],"attributes":[{"id":"A147","pred":"mondo_id","subj":"T147","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Production of soluble ST2 might be reduced by anti-ST2 treatment, and such reduction would modulate T-cell polarisation by decreasing pathogenic Th1 and Th17 cells, and increasing IL-10-producing Treg cells.67 Future research should focus on whether soluble ST2 concentrations in plasma have prognostic value in patients with COVID-19 (figure 2 )."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T347","span":{"begin":22,"end":25},"obj":"http://purl.obolibrary.org/obo/CLO_0051025"},{"id":"T348","span":{"begin":51,"end":54},"obj":"http://purl.obolibrary.org/obo/CLO_0051025"},{"id":"T349","span":{"begin":100,"end":106},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T350","span":{"begin":158,"end":163},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T351","span":{"begin":196,"end":200},"obj":"http://purl.obolibrary.org/obo/CL_0000792"},{"id":"T352","span":{"begin":201,"end":206},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T353","span":{"begin":233,"end":238},"obj":"http://purl.obolibrary.org/obo/CLO_0009985"},{"id":"T354","span":{"begin":258,"end":261},"obj":"http://purl.obolibrary.org/obo/CLO_0051025"},{"id":"T355","span":{"begin":280,"end":286},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"text":"Production of soluble ST2 might be reduced by anti-ST2 treatment, and such reduction would modulate T-cell polarisation by decreasing pathogenic Th1 and Th17 cells, and increasing IL-10-producing Treg cells.67 Future research should focus on whether soluble ST2 concentrations in plasma have prognostic value in patients with COVID-19 (figure 2 )."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T360","span":{"begin":180,"end":182},"obj":"Chemical"}],"attributes":[{"id":"A360","pred":"chebi_id","subj":"T360","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A361","pred":"chebi_id","subj":"T360","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":"Production of soluble ST2 might be reduced by anti-ST2 treatment, and such reduction would modulate T-cell polarisation by decreasing pathogenic Th1 and Th17 cells, and increasing IL-10-producing Treg cells.67 Future research should focus on whether soluble ST2 concentrations in plasma have prognostic value in patients with COVID-19 (figure 2 )."}

{"project":"LitCovid-sentences","denotations":[{"id":"T89","span":{"begin":0,"end":347},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Production of soluble ST2 might be reduced by anti-ST2 treatment, and such reduction would modulate T-cell polarisation by decreasing pathogenic Th1 and Th17 cells, and increasing IL-10-producing Treg cells.67 Future research should focus on whether soluble ST2 concentrations in plasma have prognostic value in patients with COVID-19 (figure 2 )."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1139","span":{"begin":22,"end":25},"obj":"Gene"},{"id":"1140","span":{"begin":180,"end":185},"obj":"Gene"},{"id":"1141","span":{"begin":258,"end":261},"obj":"Gene"},{"id":"1144","span":{"begin":312,"end":320},"obj":"Species"},{"id":"1145","span":{"begin":51,"end":54},"obj":"Gene"},{"id":"1161","span":{"begin":326,"end":334},"obj":"Disease"}],"attributes":[{"id":"A1139","pred":"tao:has_database_id","subj":"1139","obj":"Gene:6761"},{"id":"A1140","pred":"tao:has_database_id","subj":"1140","obj":"Gene:3586"},{"id":"A1141","pred":"tao:has_database_id","subj":"1141","obj":"Gene:6761"},{"id":"A1144","pred":"tao:has_database_id","subj":"1144","obj":"Tax:9606"},{"id":"A1145","pred":"tao:has_database_id","subj":"1145","obj":"Gene:17082"},{"id":"A1161","pred":"tao:has_database_id","subj":"1161","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Production of soluble ST2 might be reduced by anti-ST2 treatment, and such reduction would modulate T-cell polarisation by decreasing pathogenic Th1 and Th17 cells, and increasing IL-10-producing Treg cells.67 Future research should focus on whether soluble ST2 concentrations in plasma have prognostic value in patients with COVID-19 (figure 2 )."}